Funding Opportunity Title Innovation Award: Minority Health and Health Equity (U01) Clinical Trials Optional

The purpose of this funding opportunity announcement (FOA) is to fund innovative research that will strengthen and advance minority health and health equity research.Areas of interest include:Proposals that focus on advancing equity in clinical trials by supporting efforts to advance diversity in clinical

credit:


trials, equitable data efforts by increasing data available on diverse groups including, but not limited to, ethnicity, race, age, disability and geography, and equity of voices by increasing understanding of diverse patient perspectives, preferences, and unmet needs.
Related Programs

Food and Drug Administration_Research

Department of Health and Human Services


Agency: Department of Health and Human Services

Office: Food and Drug Administration

Estimated Funding: $3,000,000


Relevant Nonprofit Program Categories



Obtain Full Opportunity Text:
Full Funding Opportunity Announcement

Additional Information of Eligibility:
PIO's

Full Opportunity Web Address:
https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-22-005.html

Contact:


Agency Email Description:
Grant Specialist Email

Agency Email:


Date Posted:
2022-03-31

Application Due Date:


Archive Date:
2022-07-06


Meticulon, a project of Autism Calgary Association in partnership with the federal government and the Sinneave Family Foundation, operates as a social enterprise that renders high-tech services provided by people with autism, leveraging their natural abilities at requiring attention to detail, repetition, and sequencing.






More Federal Domestic Assistance Programs


Mortgages Insurance for Single Room Occupancy (SRO) Projects | Federal Student Temporary Employment Program | Agricultural Conservation Easement Program | Measurement and Engineering Research and Standards | Export Control and Related Border Security |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2024 Copyright Michael Saunders